Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study.

ABSTRACT: Coronavirus Disease 2019 (Covid-19) severely impacted the health, society, and economy around the world. With declining protective efficacy of primary vaccination and the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, a Covid-19 booster vaccination is being fully implemented globally. Many people received three doses of BBIBP-CorV inactivated vaccine in China and other developing countries. However, the antibody response and immune persistence of the homologous BBIBP-CorV booster vaccination is yet to be thoroughly evaluated, as previous studies focused within one month after the third dose. In this study, 97 participants were enrolled to analyze the antibody response and immune persistence within 6 months as well as the safety within 7 days after the thir

SUBMITTER: Wen GP 

PROVIDER: S-EPMC9935570 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature